Literature DB >> 22700551

Characterization of a novel variant of Mycobacterium chimaera.

J van Ingen1, W Hoefsloot2, P C A M Buijtels3, E Tortoli4, P Supply5,6,7,8, P N R Dekhuijzen2, M J Boeree2, D van Soolingen9,2,1.   

Abstract

In this study, nonchromogenic mycobacteria were isolated from pulmonary samples of three patients in the Netherlands. All isolates had identical, unique 16S rRNA gene and 16S-23S ITS sequences, which were closely related to those of Mycobacterium chimaera and Mycobacterium marseillense. The biochemical features of the isolates differed slightly from those of M. chimaera, suggesting that the isolates may represent a possible separate species within the Mycobacterium avium complex (MAC). However, the cell-wall mycolic acid pattern, analysed by HPLC, and the partial sequences of the hsp65 and rpoB genes were identical to those of M. chimaera. We concluded that the isolates represent a novel variant of M. chimaera. The results of this analysis have led us to question the currently used methods of species definition for members of the genus Mycobacterium, which are based largely on 16S rRNA or rpoB gene sequencing. Definitions based on a single genetic target are likely to be insufficient. Genetic divergence, especially in the MAC, yields strains that cannot be confidently assigned to a specific species based on the analysis of a single genetic target.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22700551     DOI: 10.1099/jmm.0.045070-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

Review 1.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Target-Specific Assay for Rapid and Quantitative Detection of Mycobacterium chimaera DNA.

Authors:  Enrique Zozaya-Valdés; Jessica L Porter; John Coventry; Janet A M Fyfe; Glen P Carter; Anders Gonçalves da Silva; Mark B Schultz; Torsten Seemann; Paul D R Johnson; Andrew J Stewardson; Ivan Bastian; Sally A Roberts; Benjamin P Howden; Deborah A Williamson; Timothy P Stinear
Journal:  J Clin Microbiol       Date:  2017-04-05       Impact factor: 5.948

3.  Mycobacterium chimaera-induced tenosynovitis in a patient with rheumatoid arthritis.

Authors:  Ryu Watanabe; Hiroto Seino; Shinji Taniuchi; Ryotaro Igusa
Journal:  BMJ Case Rep       Date:  2020-01-19

4.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

5.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

Review 6.  Risk Management in the New Frontier of Professional Liability for Nosocomial Infection: Review of the Literature on Mycobacterium Chimaera.

Authors:  Matteo Bolcato; Daniele Rodriguez; Anna Aprile
Journal:  Int J Environ Res Public Health       Date:  2020-10-07       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.